These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25142140)
1. High and prolonged sulfamidase secretion by the liver of MPS-IIIA mice following hydrodynamic tail vein delivery of antibiotic-free pFAR4 plasmid vector. Quiviger M; Arfi A; Mansard D; Delacotte L; Pastor M; Scherman D; Marie C Gene Ther; 2014 Dec; 21(12):1001-7. PubMed ID: 25142140 [TBL] [Abstract][Full Text] [Related]
2. Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer. Ruzo A; Marcó S; García M; Villacampa P; Ribera A; Ayuso E; Maggioni L; Mingozzi F; Haurigot V; Bosch F Hum Gene Ther; 2012 Dec; 23(12):1237-46. PubMed ID: 22909060 [TBL] [Abstract][Full Text] [Related]
3. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987 [TBL] [Abstract][Full Text] [Related]
5. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier. Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464 [TBL] [Abstract][Full Text] [Related]
6. SGSH gene transfer in mucopolysaccharidosis type IIIA mice using canine adenovirus vectors. Lau AA; Hopwood JJ; Kremer EJ; Hemsley KM Mol Genet Metab; 2010 Jun; 100(2):168-75. PubMed ID: 20231109 [TBL] [Abstract][Full Text] [Related]
9. A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome. Winner LK; Beard H; Hassiotis S; Lau AA; Luck AJ; Hopwood JJ; Hemsley KM Hum Gene Ther; 2016 May; 27(5):363-75. PubMed ID: 26975339 [TBL] [Abstract][Full Text] [Related]
10. Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice. Duncan FJ; Naughton BJ; Zaraspe K; Murrey DA; Meadows AS; Clark KR; Newsom DE; White P; Fu H; McCarty DM Mol Ther; 2015 Apr; 23(4):638-47. PubMed ID: 25592334 [TBL] [Abstract][Full Text] [Related]
11. Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transfer. McIntyre C; Byers S; Anson DS J Gene Med; 2010 Sep; 12(9):717-28. PubMed ID: 20683858 [TBL] [Abstract][Full Text] [Related]
12. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA. Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731 [TBL] [Abstract][Full Text] [Related]
13. Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse-Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse. Boado RJ; Lu JZ; Hui EK; Pardridge WM Mol Pharm; 2018 Feb; 15(2):602-608. PubMed ID: 29251941 [TBL] [Abstract][Full Text] [Related]
14. Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice. Ruzo A; Garcia M; Ribera A; Villacampa P; Haurigot V; Marcó S; Ayuso E; Anguela XM; Roca C; Agudo J; Ramos D; Ruberte J; Bosch F Mol Ther; 2012 Feb; 20(2):254-66. PubMed ID: 22008915 [TBL] [Abstract][Full Text] [Related]
15. Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease. Saville JT; Derrick-Roberts ALK; McIntyre C; Fuller M Hum Gene Ther; 2021 Apr; 32(7-8):420-430. PubMed ID: 33339477 [TBL] [Abstract][Full Text] [Related]
16. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery. Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715 [TBL] [Abstract][Full Text] [Related]
17. An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA. Gray AL; O'Leary C; Liao A; Agúndez L; Youshani AS; Gleitz HF; Parker H; Taylor JT; Danos O; Hocquemiller M; Palomar N; Linden RM; Henckaerts E; Holley RJ; Bigger BW Hum Gene Ther; 2019 Sep; 30(9):1052-1066. PubMed ID: 31020862 [TBL] [Abstract][Full Text] [Related]